425 related articles for article (PubMed ID: 24683034)
1. Nanomedicine: the promise and challenges in cancer chemotherapy.
Naguib YW; Cui Z
Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
[No Abstract] [Full Text] [Related]
2. Nanoparticle approaches to combating drug resistance.
Moon JH; Moxley JW; Zhang P; Cui H
Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
[TBL] [Abstract][Full Text] [Related]
3. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
4. New strategies in melanoma therapy: can nanoparticles overcome chemoresistance?
Badea I
Nanomedicine (Lond); 2017 Jul; 12(14):1623-1626. PubMed ID: 28635551
[No Abstract] [Full Text] [Related]
5. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
6. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
8. Nanomedicine for multimodality treatment of cancer.
Mi Y; Guo Y; Feng SS
Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
[No Abstract] [Full Text] [Related]
9. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
[TBL] [Abstract][Full Text] [Related]
10. Can a nanoparticle that mimics Salmonella effectively combat tumor chemotherapy resistance?
Mercado-Lubo R; McCormick BA
Nanomedicine (Lond); 2017 Apr; 12(7):705-710. PubMed ID: 28322607
[No Abstract] [Full Text] [Related]
11. Nanomedicine: sizing up targets with nanoparticles.
Minchin R
Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
[No Abstract] [Full Text] [Related]
12. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic and diagnostic applications of nanoparticles.
Youns M; Hoheisel JD; Efferth T
Curr Drug Targets; 2011 Mar; 12(3):357-65. PubMed ID: 20955146
[TBL] [Abstract][Full Text] [Related]
14. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
[TBL] [Abstract][Full Text] [Related]
15. Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy.
Beretta GL; Cavalieri F
Curr Med Chem; 2016; 23(1):3-22. PubMed ID: 26438248
[TBL] [Abstract][Full Text] [Related]
16. Advances in stimuli responsive nanobiomaterials for cancer therapy.
Sampathkumar K; Arulkumar S; Ramalingam M
J Biomed Nanotechnol; 2014 Mar; 10(3):367-82. PubMed ID: 24730233
[TBL] [Abstract][Full Text] [Related]
17. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine and drug delivery.
Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
[TBL] [Abstract][Full Text] [Related]
19. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
Kibria G; Hatakeyama H; Harashima H
Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
[TBL] [Abstract][Full Text] [Related]
20. Targeting for delivery.
Nat Biomed Eng; 2019 Sep; 3(9):671-672. PubMed ID: 31501568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
